Close

Analyst Ratings for Athira Pharma (ATHA) [Neutrals]

ATHA Rating Summary

ATHA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ATHA
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $13.83 (+356.5%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 14%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/23/2022 Stifel Paul Matteis Downgrade Hold
(Buy)
5.00
(36.00)
2.85
(3.03)
6.32% Details
6/23/2022 Jefferies Andrew Tsai Downgrade Hold
(Buy)
3.00
(32.00)
8.45
(3.03)
-64.14% Details
Like ATHA Ratings? Also take a look at PCVX, WVE, NBR

ATHA Ratings News